Patients treated with OMMs, except for orlistat, were more likely to achieve a TBWL of at least 5% compared to placebo
Improving Functional Pathways for Weight Management Enhancement of Beneficial Pathways: The study identified increased pathways related to SCFA production and the degradation of simple sugars
Societies Exp
Affordability and Access Barriers The high cost of GLP-1 drugs remains a critical issue , with monthly list prices reported as follows: Wegovy : $1,350 Zepbound : $1,060 (Source: Institute for Clinical and Economic Review) Because long-term use is generally required to maintain weight loss, the financial burden on health plans is substantial
The general framework most providers follow: For patients who are still actively losing weight, a consultation is still worthwhile your provider can assess your current changes, identify what to start now vs
True sobriety requires time